XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

FAIR VALUE MEASUREMENTS (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis | Financial assets (excluding cash held in operating accounts and time deposits) and liabilities measured at fair value on a recurring basis, as of the dates indicated below, were presented on our Condensed Consolidated Balance Sheets as follows:
|  |  | Quoted Prices in Active Markets for Identical Assets |  | Significant Other Observable Inputs |  |
As of March 31, 2025 (In thousands) | Total |  | (Level 1) |  | (Level 2) |  |
Assets |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Corporate debt securities | $ | 13,176 |  |  | $ | — |  |  | $ | 13,176 |  |  |
Money market funds and other | 1,275,947 |  |  | 1,275,947 |  |  | — |  |  |
U.S. Treasury securities | 25,874 |  |  | — |  |  | 25,874 |  |  |
Marketable securities: |  |  |  |  |  |  |
Corporate debt securities | 959,272 |  |  | — |  |  | 959,272 |  |  |
Municipal securities | 55,540 |  |  | — |  |  | 55,540 |  |  |
U.S. Government agency securities | 96,051 |  |  | 96,051 |  |  | — |  |  |
U.S. Treasury securities | 776,974 |  |  | 693,266 |  |  | 83,708 |  |  |
Equity securities | 12,255 |  |  | 12,255 |  |  | — |  |  |
Total cash equivalents and marketable securities(1) | 3,215,089 |  |  | 2,077,519 |  |  | 1,137,570 |  |  |
Other current assets: |  |  |  |  |  |  |
Derivative assets | 19,466 |  |  | — |  |  | 19,466 |  |  |
Other non-current assets: |  |  |  |  |  |  |
Executive Deferred Savings Plan | 320,206 |  |  | 285,578 |  |  | 34,628 |  |  |
Total financial assets(1) | $ | 3,554,761 |  |  | $ | 2,363,097 |  |  | $ | 1,191,664 |  |  |
Liabilities |  |  |  |  |  |  |
Derivative liabilities | $ | (22,624) |  |  | $ | — |  |  | $ | (22,624) |  |  |
Total financial liabilities | $ | (22,624) |  |  | $ | — |  |  | $ | (22,624) |  |  |
________________ (1) Excludes cash of $473.1 million held in operating accounts and time deposits of $340.5 million (of which $70.0 million were cash equivalents) as of March 31, 2025.
|  |  | Quoted Prices in Active Markets for Identical Assets |  | Significant Other Observable Inputs |  |
As of June 30, 2024 (In thousands) | Total |  | (Level 1) |  | (Level 2) |  |
Assets |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |
Corporate debt securities | $ | 2,312 |  |  | $ | — |  |  | $ | 2,312 |  |  |
Money market funds and other | 1,585,832 |  |  | 1,585,832 |  |  | — |  |  |
U.S. Treasury securities | 35,158 |  |  | — |  |  | 35,158 |  |  |
Marketable securities: |  |  |  |  |  |  |
Corporate debt securities | 771,920 |  |  | — |  |  | 771,920 |  |  |
Municipal securities | 41,159 |  |  | — |  |  | 41,159 |  |  |
U.S. Government agency securities | 105,874 |  |  | 105,874 |  |  | — |  |  |
U.S. Treasury securities | 716,148 |  |  | 476,230 |  |  | 239,918 |  |  |
Equity securities | 25,566 |  |  | 25,566 |  |  | — |  |  |
Total cash equivalents and marketable securities(1) | 3,283,969 |  |  | 2,193,502 |  |  | 1,090,467 |  |  |
Other current assets: |  |  |  |  |  |  |
Derivative assets | 36,503 |  |  | — |  |  | 36,503 |  |  |
Other non-current assets: |  |  |  |  |  |  |
Executive Deferred Savings Plan | 303,365 |  |  | 272,816 |  |  | 30,549 |  |  |
Total financial assets(1) | $ | 3,623,837 |  |  | $ | 2,466,318 |  |  | $ | 1,157,519 |  |  |
Liabilities |  |  |  |  |  |  |
Derivative liabilities | $ | (15,683) |  |  | $ | — |  |  | $ | (15,683) |  |  |
Total financial liabilities | $ | (15,683) |  |  | $ | — |  |  | $ | (15,683) |  |  |
________________ (1) Excludes cash of $287.6 million held in operating accounts and time deposits of $932.4 million (of which $66.2 million were cash equivalents) as of June 30, 2024.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration